Who
Kumar Budur
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Harmony Biosciences Holdings.
In numbers
- Trades disclosed
- 80
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $6.2M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 24 Jan 2024
- Last trade
- 18 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —10,406 at $0.00 | filing |
| 18 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —25,446 at $0.00 | filing |
| 18 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —10,406 at $0.00 | filing |
| 18 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —25,446 at $0.00 | filing |
| 18 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code M | $319K10,406 at $30.69 | filing |
| 18 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code M | $770K25,446 at $30.27 | filing |
| 18 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Sold | $1.5M35,852 at $43.05 | filing |
| 18 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code M | $319K10,406 at $30.69 | filing |
| 18 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code M | $770K25,446 at $30.27 | filing |
| 18 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Sold | $1.5M35,852 at $43.05 | filing |
| 17 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —400 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —400 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —400 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences Holdingsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —400 at $0.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code M | $12K400 at $30.69 | filing |
| 17 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code M | $12K400 at $30.27 | filing |
| 17 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Sold | $34K800 at $43.00 | filing |
| 17 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code M | $12K400 at $30.69 | filing |
| 17 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Code M | $12K400 at $30.27 | filing |
| 17 Sep 2026filed 18 Sep 2026 | HRMY Harmony Biosciences HoldingsPharmaceuticals | SEC FORM 4 Sold | $34K800 at $43.00 | filing |
News
Harmony Biosciences (NASDAQ:HRMY) Insider Kumar Budur Sells 800 Sharesthemarketsdaily.com · 18 Sep 2026Harmony Biosciences (NASDAQ:HRMY) Insider Kumar Budur Sells 28,454 Shares of Stockdailypolitical.com · 10 Sep 2026Kumar Budur Sells 5,500 Shares of Harmony Biosciences (NASDAQ:HRMY) Stockthemarketsdaily.com · 10 Sep 2026Harmony Biosciences drop amid court hearing on Wakix patentHRMY · seekingalpha.com · 22 Oct 2026Centene, Harmony Biosciences lead list of undervalued healthcare stocks (XLV:NYSEARCA)HRMY · seekingalpha.com · 22 Oct 2026Harmony Biosciences (NASDAQ:HRMY) Given "Buy" Rating at Needham & Company LLCHRMY · themarketsdaily.com · 20 Oct 2026
3 headlines in the last 90 days name Kumar Budur; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.